Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Dong-A ST

Status: Unknown

Conditions: Diabetes Mellitus, Type 2

Treatments: Drug: Metformin and Evogliptin; Drug: Evogliptin

Study type: Observational

Funder types: Industry

Identifiers

NCT04326166

DA1229_DM_OS

Details and patient eligibility

About

Multi-center, open, non-intervention and observational study to Evaluate the efficacy and safety of Suganon tab. or Sugamet XR tab. in patients with Type 2 diabetes

Enrollment: 1,971 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. The subject is aged ≥19 years
2. The subject has type 2 diabetes mellitus

Exclusion criteria

1. The subject has a contraindication

Trial design

1,971 participants in 3 patient groups

Group A

Description:

Patients who receive Double therapy or Insulin

Treatment:

Drug: Evogliptin

Drug: Evogliptin

Group B

Description:

Patients who receive DPP-4 inhibitor

Treatment:

Drug: Evogliptin

Drug: Evogliptin

Group C

Description:

Drug-naïve patients

Treatment:

Drug: Metformin and Evogliptin